Yoseph Shaaltiel Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Yoseph Shaaltiel.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Yoseph Shaaltiel. Yoseph Shaaltiel is an Executive VP, R&D in Protalix BioTherapeutics, Inc. ($PLX).
Address: C/O PROTALIX BIOTHERAPEUTICS 2 SNUNIT STREET SCIENCE PARK, POB 455 CARMIEL 20100Israel
Companies in which Yoseph Shaaltiel is an Insider
Protalix BioTherapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Yoseph Shaaltiel: Executive VP, R&D
Holdings: 883,754 shares
Current Value: $698,166
Latest Transaction: Mar 25 2010
$PLX Market Capitalization: $78.10M
$PLX Previous Close: $0.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Yoseph Shaaltiel
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 25 2010 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 7.00 | 50,000 | 350,000 | 883,754 | 933.8 K to 883.8 K (-5.35 %) |
| Mar 25 2010 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 7.08 | 202,700 | 1,435,116 | 933,754 | 1.1 M to 933.8 K (-17.84 %) |
| Mar 25 2010 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 7.02 | 127,300 | 893,646 | 1,136,454 | 1.3 M to 1.1 M (-10.07 %) |
| Feb 26 2010 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Option Exercise | A | 6.90 | 145,000 | 1,000,500 | 145,000 | |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 9.43 | 43,120 | 406,622 | 1,263,754 | 1.3 M to 1.3 M (-3.30 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 9.39 | 25,680 | 241,135 | 1,306,874 | 1.3 M to 1.3 M (-1.93 %) |
| Oct 19 2009 | PLX | Protalix BioTherap ... | Shaaltiel Yoseph | Executive VP, R&D | Sell | S | 9.39 | 31,200 | 292,968 | 1,332,554 | 1.4 M to 1.3 M (-2.29 %) |